<DOC>
	<DOCNO>NCT01061671</DOCNO>
	<brief_summary>To determine effect daily administration 40 mgms simvastatin take least 12 month ( range 12-36 month ) frequency exacerbation chronic obstructive lung disease ( COPD ) patient moderate severe COPD prone exacerbation indication statin treatment .</brief_summary>
	<brief_title>Simvastatin Therapy Moderate Severe COPD</brief_title>
	<detailed_description>COPD exacerbation common complication significantly contribute high morbidity , mortality cost associate COPD . COPD exacerbation associate heighten lung inflammation may systemic implication ( e.g. , peripheral muscle weakness , cognitive impairment , depression , stroke , acute coronary syndrome , atherosclerosis ) . Statins potent agent significantly reduce vascular event patient increase risk due prior cardiac cerebral vascular event elevate lipid profile . Statins pleiotropic effect extend well beyond lipid lowering effect may potent anti-inflammatory agent . Retrospective data conduct COPD patient indicate statin use associate markedly decrease rate COPD hospitalization stabilization lung function . Decreases mortality COPD due complication flu-like illness death due cardiovascular event also report . Inflammatory biomarkers ( C-reactive protein interleukin- 6 ) report elevated moderate severe COPD patient prone exacerbation . Inflammatory biomarkers ( C-reactive protein interleukin- 6 ) report reduced statin therapy patient hyperlipidemia cardiovascular disease . Treatments effectively lessen prevalence severity COPD exacerbation desperately need</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1 . Male female subject , 4080 year age . 2 . Clinical diagnosis least moderate COPD define GOLD criterion : 1 . Postbronchodilator FEV1 ( forced expiratory volume one second ) /FVC ( forced vital capacity ) &lt; 70 % , 2 . Postbronchodilator FEV1 ( forced expiratory volume one second ) &lt; 80 % predict , without chronic symptom ( i.e. , cough , sputum production ) . 3 . Cigarette consumption 10 packyears . Patients may may active smoker . 4 . Must meet one follow 4 condition 1 . Be use supplemental oxygenate 2 . Receiving course systemic corticosteroid and/or antibiotic respiratory problem past year , 3 . Visiting Emergency Department COPD exacerbation within past year , 4 . Being hospitalize COPD ( Chronic Obstructive Pulmonary Disease ) exacerbation within past year 5 . Willingness make return visit availability telephone duration study . 6 . Free active coronary disease 7 . Subject expect life expectancy &gt; 36 month 1 . Patients : 1. statin drug . 2. statin base establish risk stratification use ATPIII ( Adult Treatment Panel ) determine 10 year risk . 2 . Documented history active coronary heart disease , unstable angina , prior myocardial infarction , stroke , symptomatic peripheral vascular carotid artery disease , congestive heart failure within past 3 month . 3 . A diagnosis asthma . 4 . The presence diagnosis COPD result patient either medically unstable , predicted life expectancy &lt; 3 year . 5 . Special patient group : prisoner , pregnant woman , institutionalized patient 6 . Women risk become pregnant study ( premenopausal ) refuse use acceptable birth control ( hormonebased oral barrier contraceptive ) duration study . 7 . Woman use estradiol compound contraception . Postmenopausal woman estradiol compound hormone replacement therapy allow trial . 8 . Participants otherwise meet inclusion criterion enrol minimum four week recent acute exacerbation . 9 . A clinical diagnosis bronchiectasis define production &gt; onehalf cup purulent sputum/day . 10 . Participants use niacin , azole antifungal ( itraconazole , ketoconazole , posaconazole ) , fibric acid derivative , erythromycin , clarithromycin , telithromycin , diltiazem , amlodipine , ranolazine , HIV protease inhibitor ( indinavir ) , amiodarone , gemfibrozil , cyclosporine , verapamil , danazol , nefazodone , red yeast rice extract exclude 11 . Active liver disease . Active liver disease define ALT ( alanine aminotransferase ) , AST ( aspartate aminotransferase ) great 1.5 time upper limit normal . 12 . Patients renal failure define serum creatinine great 3mg/dl . 13 . Alcoholism . Alcoholism define &gt; 35 drink per week . A drink define one bottle beer , one 8ounce glass wine , one ounce hard liquor . 14 . Hypersensitivity HMG CoA ( 3hydroxy3methylglutarylcoenzyme A ) reductase inhibitor . Hypersensitivity define allergic reaction statin , prior history myopathy , rhabdomyolysis previous intolerance statin use . 15 . Participants drink great 4 cup ( 1qt ) grapefruit juice per day . 16 . Participants drink great 3 cup green tea per day . 17 . Diabetics exclude . Diabetics define : 1 . A CURRENT physician diagnosis diabetes OR 2 . CURRENT use diabetic med OR 3 . Elevated HbA1c &gt; 6.5 % 18 . The discretion Principal Investigator potential participant reliable study subject complete study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Exacerbation</keyword>
	<keyword>Lung function</keyword>
	<keyword>Cardiovascular</keyword>
	<keyword>Smoking</keyword>
	<keyword>Statins</keyword>
	<keyword>Simvastatin</keyword>
</DOC>